Clinically Proven. Globally Trusted. Patient-Focused.

At Gilla Pharma, we believe the future of oncology lies in precision medicine — treatments designed to target cancer at its molecular source. By combining innovative targeted therapies with evidence-based medications, we help healthcare providers deliver more effective and personalized cancer care.

Our oncology portfolio supports hospitals, oncology centers, and licensed healthcare providers across Myanmar, Vietnam, Cambodia, Laos, and Indonesia.

What is Precision Medicine in Oncology?

Precision medicine uses genetic, molecular, and biomarker information to:

• Identify specific cancer mutations
• Select targeted therapies
• Reduce unnecessary toxicity
• Improve overall treatment outcomes

Unlike traditional chemotherapy alone, targeted treatments focus on cancer-specific pathways — helping improve survival and quality of life.

Our Oncology Portfolio

We supply a comprehensive range of:

Targeted Therapies

• CDK4/6 inhibitors
• PARP inhibitors
• HER2-targeted monoclonal antibodies
• Tyrosine kinase inhibitors

Biologic Treatments

• Monoclonal antibodies
• Immuno-oncology agents

Supportive & Bone Health Therapies

• Bisphosphonates
• Hematology support agents
• Adjuvant cancer medications

All products are sourced from globally recognized manufacturers and comply with applicable pharmaceutical regulations.

Designed to Target Disease at Its Source

Modern oncology treatments work by:

• Blocking tumor growth signals
• Preventing DNA repair in cancer cells
• Activating immune-mediated tumor destruction
• Reducing skeletal-related complications

By focusing on specific molecular pathways, these therapies aim to provide better clinical outcomes compared to non-selective treatment approaches.

Quality & Regulatory Commitment

At Gilla Pharma, quality is non-negotiable.

We ensure:

• Strict supplier verification
• Regulatory-compliant documentation
• Controlled storage & secure distribution
• Cold-chain handling for biologics
• Ethical sourcing practices

Every product we supply meets high pharmaceutical quality standards suitable for hospital and oncology center use.

Supporting Healthcare Providers Across Southeast Asia

We proudly serve:

• Myanmar
• Vietnam
• Cambodia
• Laos
• Indonesia

Our team works closely with oncology professionals to ensure reliable supply, transparent documentation, and timely distribution.

Why Choose Gilla Pharma?

• Specialized oncology medicine supplier
• Competitive wholesale pricing
• Reliable international logistics
• Focused on targeted & innovative cancer therapies
• Dedicated support for licensed healthcare institutions

Our Commitment to Better Patient Outcomes

Precision medicine is not just innovation — it is responsibility. By supplying clinically proven and globally trusted oncology therapies, Gilla Pharma supports healthcare providers in delivering treatment strategies tailored to each patient’s cancer profile.

Partner With Us

For product inquiries, supply partnerships, or regulatory documentation, contact Gilla Pharma today.

Email: info@gillapharma.com
Phone: +91 95491 32929 | +84 7645 21324